Condensed Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2023	$ 139,424	$ 7	$ 542,805	$ (106)	$ (403,282)
Balance, shares at Dec. 31, 2023		68,330,342
Issuance of common stock and pre-funded warrants, net of issuance costs	46,762	$ 1	46,761
Issuance of common stock and pre-funded warrants, net of issuance costs, shares		8,888,890
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares		246,708
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	11		11
Issuance of common stock upon exercise of pre-funded warrants	1		1
Issuance of common stock upon exercise of pre-funded warrants, shares		1,051,594
Stock-based compensation	4,224		4,224
Other comprehensive income (loss)	(14)			(14)
Net loss	(32,228)				(32,228)
Balance at Mar. 31, 2024	158,180	$ 8	593,802	(120)	(435,510)
Balance, shares at Mar. 31, 2024		78,517,534
Balance at Dec. 31, 2024	92,854	$ 8	607,229	28	(514,411)
Balance, shares at Dec. 31, 2024		86,542,340
Issuance of common stock and warrants, net of issuance costs	48,801	$ 8	48,793
Issuance of common stock and warrants, net of issuance costs, shares		75,000,000
Issuance of common stock in connection with at-the-market sales, net of issuance costs	912		912
Issuance of common stock in connection with at-the market sales, net of issuance costs , Shares		822,566
Issuance of common stock upon vesting of restricted stock units, shares		295,191
Stock-based compensation	3,731		3,731
Other comprehensive income (loss)	(38)			(38)
Net loss	(26,864)				(26,864)
Balance at Mar. 31, 2025	$ 119,396	$ 16	$ 660,665	$ (10)	$ (541,275)
Balance, shares at Mar. 31, 2025		162,660,097